SCHEMBL6169737

SCHEMBL6169737

CC1(Cc2ccncc2-c2ccccc2Cl)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.43

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.43
GPBAR1 Q8TDU6 4/20 0.34
MAPT P10636 2/20 0.34
PTGS2 P35354 2/20 0.33
ITGAL P20701 1/20 0.33
NAMPT P43490 1/20 0.33
AR P10275 4/20 0.33
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 2/20 0.32
LMNA P02545 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175293 0.89 IGF1R (0.45) IGF1RPTGS2NAMPTARALDH1A1
SCHEMBL6171403 0.88 IGF1R (0.43) IGF1RMAPTITGALNAMPTAR
SCHEMBL6171779 0.87 IGF1R (0.40) IGF1RMAPTITGALNAMPTAR
SCHEMBL6171903 0.86 IGF1R (0.45) IGF1RPTGS2NAMPTARALDH1A1
SCHEMBL6172113 0.86 IGF1R (0.40) IGF1RMAPTPTGS2ITGALNAMPT
SCHEMBL6173951 0.85 IGF1R (0.44) IGF1RITGALAR
SCHEMBL6172334 0.84 IGF1R (0.40) IGF1RPTGS2NAMPTARALDH1A1
SCHEMBL6175255 0.84 IGF1R (0.44) IGF1RMAPTITGALNAMPTAR
SCHEMBL6175170 0.84 IGF1R (0.44) IGF1RMAPTPTGS2ITGALNAMPT
SCHEMBL6175003 0.82 CYP3A4 (0.43) IGF1RMAPTPTGS2ARALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed